Quarterly report pursuant to Section 13 or 15(d)

Restructuring and Impairment (Tables)

v3.23.3
Restructuring and Impairment (Tables)
9 Months Ended
Sep. 30, 2023
Restructuring and Impairment  
Schedule of restructuring and impairment charges

Three Months Ended

Nine Months Ended

September 30, 2023

September 30, 2023

Restructuring

$

365,483

$

372,210

Impairment

857,109

857,109

Total restructuring and impairment

$

1,222,592

$

1,229,319

Summary of company's restructuring-related liability

    

    

Restructuring

    

Payments/

    

Charges

Utilization

Liability at

(Nine Months Ended

(Nine Months Ended

Liability at

    

December 31, 2022

    

September 30, 2023)

    

September 30, 2023)

    

September 30, 2023

Research and development contract termination costs

$

311,110

$

2,490

$

(313,600)

$

Employee termination benefits

369,630

(184,535)

185,095

Other

 

4,922

 

90

 

(5,012)

 

Total Accrued restructuring

$

316,032

$

372,210

$

(503,147)

$

185,095